Please Wait...

'Intelligent Monitoring' to Be Showcased at Pharma Industry Events

BioClinica Global Tour Features Compass Risk-Based Monitoring Solution

February 20, 2015

BioClinica®, Inc., a specialty clinical trials services and technology provider, today announced that due to heightened interest in its 'Intelligent Monitoring' solution, a global risk-based monitoring tour will kick-off with its European User Conference in Barcelona, Spain on February 24 and 25. Presentations at international trade events will give industry professionals an opportunity to learn about innovative technology that transforms clinical trial monitoring.

Compass takes a proactive, risk-based, quality management approach using centralized and off-site monitoring tools. In addition to technology, BioClinica provides expertise and consulting to ensure successful implementation. BioClinica Vice President of Innovation Courtney McBean explains, "Many research organizations are discovering tangible value in the ability to view meaningful performance across all of their investigative sites and make better decisions about how trials are run." McBean adds, "Compass helps reduce risk and improve quality encompassing the clinical trial lifecycle."

Compass co-developers, Courtney McBean and Trevor McCaw, and Jonathan Andrus, Vice President, Strategic Accounts, will be expert panelists or presenters at several events in coming months including:

BioClinica is a sponsor and/or exhibitor, giving attendees an opportunity to interact with Company representatives and experience product demonstrations. To request a meeting with BioClinica, call the hotline at 1-888-392-7456, email sales@bioclinica.com, or use the online Contact Us form.

BioClinica will also host a complimentary webinar, Overcoming Barriers to Risk Based Monitoring on March 5 at 10 AM, EST.  Clinical data management expert Mireille Zerola of Boehringer Ingelheim and TransCelerate BioPharma RBM work stream member, will present with McBean on challenges in transitioning to RBM and how to overcome them.

Follow BioClinica on the Trial Blazers blog at http://www.bioclinica.com/blog, and on Twitter at http://twitter.com/bioclinica.

About Bioclinica

Bioclinica is a global life science provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica's hundreds of experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval. The company's cloud-based offerings include medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments and budget forecasting; pharmacovigilance; trial management; and risk-based monitoring solutions. A true multifaceted partner to trial sponsors and Contract Research Organizations (CROs), Bioclinica offers a global network of research sites and patient recruitment services to provide committed, detail-focused service through all stages of drug development. The company's thousands of employees serve more than 400 pharmaceutical, biotechnology and device organizations – including all the top 20 biopharmaceutical companies and leading CROs – through a network of offices in the U.S., Europe, and Asia.

Learn more about Bioclinica and our Clinical Adjudication and other offerings at www.Bioclinica.com and in the Bioclinica Blog. Follow the latest company news and happenings on LinkedIn and Twitter.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @virtue_insight: #VIphv We are delighted to announce our new Gold Sponsor @bioclinica for our 16th Pharmacovigilance 2018 https://t.co/h…
bioclinica (5 days ago)
RT @bioclinica: Tackling the costly issue of drug supply waste in clinical trials. Find out how Novo Nordisk & other global pharmas R embra…
bioclinica (5 days ago)
Tackling the costly issue of drug supply waste in clinical trials. Find out how Novo Nordisk & other global pharmas… https://t.co/iW7Q9DfVgQ
bioclinica (2 weeks ago)
Background & key considerations to help #pharma prepare for new FDA blood pressure draft guidance issued in May. Ac… https://t.co/07dJeeD35E
bioclinica (3 weeks ago)
Tackling the costly issue of drug supply waste in clinical trials. Find out how Novo Nordisk & other global pharmas… https://t.co/tSx5tm2rgg
bioclinica (4 weeks ago)
DYK @bioclinica offers full-svc global clinical data mgmt svcs customizable to your study & program needs? Our high… https://t.co/dyXDiCtWd8
bioclinica (4 weeks ago)

Latest Blogs:

Blood pressure monitor
Prescription box
Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations